Posted in | News | Chemical Sensor

Smiths Detection’s ACE-ID Handheld Identifier Detects Explosives, Toxic Chemicals and Narcotics

Smiths Detection today introduces ACE-ID, an advanced, handheld chemical identifier that has been rigorously tested to ensure its safe use when analyzing suspected explosives. It also identifies toxic industrial chemicals (TICs) and narcotics.

 

 

In 20 seconds or less, ACE-ID allows explosive ordnance division (EOD) teams, bomb squads, HazMat technicians, and law enforcement officers to identify unknown solids and water-based solutions. It uses Raman spectroscopy, a laser-based technique to identify chemicals. This eliminates the need to handle potentially dangerous substances and allows analysis through certain types of glass and plastics. ACE-ID’s advanced laser platform also minimizes heat to substances that could ignite if explosive.

Ian May, Senior Vice President of Sales, Smiths Detection, said: “Our mission is to help protect communities and those who serve them. ACE-ID provides an unparalleled capability to identify explosives with confidence and without the need for physical contact.”

For more information about ACE-ID, please visit: https://www.smithsdetection.com/

Smiths Detection offers advanced security solutions in civil and military markets worldwide, developing and manufacturing government-regulated technology products that help detect and identify explosives, chemical and biological agents, radiological and nuclear threats, narcotics, weapons and contraband. It is part of Smiths Group, a global leader in applying integrated, advanced technologies to markets in threat and contraband detection, energy, medical devices, communications and engineered components. Smiths Group employs around 23,000 people in more than 50 countries.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.